Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 2,028 INR
Change Today +18.45 / 0.92%
Volume 1.1M
LPC On Other Exchanges
Natl India
As of 7:06 AM 10/13/15 All times are local (Market data is delayed by at least 15 minutes).

lupin ltd (LPC) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/6/15 - 2,129
52 Week Low
10/16/14 - 1,307
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for LUPIN LTD (LPC)

Related News

No related news articles were found.

lupin ltd (LPC) Related Businessweek News

No Related Businessweek News Found

lupin ltd (LPC) Details

Lupin Limited, a pharmaceutical company, produces, develops, and markets a range of branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. It offers formulations for use in the areas of cardiovascular, diabetology, asthma, pediatric, central nervous system (CNS), gastro-intestinal, anti-diabetic, anti-infective, NSAID, anti- tuberculosis, cephalosporin, gynaecology, and other therapeutic areas; and APIs for use in therapeutic areas of antibiotics, anti-tuberculosis, cardiovascular, CNS, analgesics, and anti-gout. The company also develops drug delivery technologies; and creates and develops biosimilars for various therapeutic indications, such as oncology, inflammation, antivirals, osteoporosis, rheumatoid arthritis, and ophthalmics. In addition, it engages in the novel drug discovery and development programs for use in the treatment of CNS disorders, oncology, immunology, pain and inflammation, infections, and metabolic/endocrine disorders. Lupin Limited has a strategic licensing agreement with InspiRX Inc. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.

15,000 Employees
Last Reported Date: 06/27/15
Founded in 1968

lupin ltd (LPC) Top Compensated Officers

Founder, Chairman, Chairman of Allotment Comm...
Total Annual Compensation: 36.7M
Chief Financial Officer and Member of Risk Ma...
Total Annual Compensation: 79.2M
Vice Chairman, Chairman of Share Transfer Com...
Total Annual Compensation: 139.4M
Managing Director, Executive Director, Member...
Total Annual Compensation: 81.5M
Executive Director, Member of Share Transfer ...
Total Annual Compensation: 4.6M
Compensation as of Fiscal Year 2015.

lupin ltd (LPC) Key Developments

Lupin Limited, Board Meeting, Oct 06, 2015

Lupin Limited, Board Meeting, Oct 06, 2015. Agenda: To allot 21,073 fully paid up equity shares of INR 2 each.

Lupin Limited, Board Meeting, Sep 23, 2015

Lupin Limited, Board Meeting, Sep 23, 2015. Agenda: To approve the allotment of 102,129 fully paid up equity shares of INR 2 each.

Lupin Eyes Sinclair For $500 Million

Lupin Limited (BSE:500257) is said to have thrown its hat into the ring to acquire Sinclair IS Pharma plc (AIM:SPH) in a deal topping $500 million, people familiar with the matter said, reported The Economic Times on September 17, 2015. Sinclair has appointed NM Rothschild to help find a buyer for all or part of its business.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LPC:IN 2,028.25 INR +18.45

LPC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alkermes PLC $57.89 USD -1.18
Cadila Healthcare Ltd 419.40 INR +12.30
Cipla Ltd/India 679.05 INR +2.70
Dr Reddy's Laboratories Ltd 4,228 INR +40.55
H Lundbeck A/S kr190.00 DKK +0.20
View Industry Companies

Industry Analysis


Industry Average

Valuation LPC Industry Range
Price/Earnings 38.9x
Price/Sales 7.1x
Price/Book 10.0x
Price/Cash Flow 32.7x
TEV/Sales 6.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LUPIN LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at